Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
CSL ( (AU:CSL) ) just unveiled an announcement.
CSL Limited has reported an update to its ongoing on-market share buy-back program for its ordinary fully paid securities traded on the ASX. The update, dated 24 March 2026, reflects the company’s continued use of buy-backs as part of its capital management strategy and engagement with shareholders.
The latest notification shows that CSL has repurchased a cumulative 4,851,865 shares prior to the most recent trading day, and a further 90,239 shares on the previous day alone. This steady execution of the buy-back may incrementally reduce the company’s share count over time, potentially supporting earnings per share and signalling management’s confidence in the company’s valuation.
The most recent analyst rating on (AU:CSL) stock is a Hold with a A$155.00 price target. To see the full list of analyst forecasts on CSL stock, see the AU:CSL Stock Forecast page.
More about CSL
CSL Limited is a publicly listed company on the ASX that issues ordinary fully paid shares under the ticker CSL. The company operates in the healthcare and biotechnology sector, with its shares actively traded and subject to capital management activities such as on-market buy-backs.
YTD Price Performance: -18.74%
Average Trading Volume: 1,234,081
Technical Sentiment Signal: Sell
Current Market Cap: A$67.22B
See more data about CSL stock on TipRanks’ Stock Analysis page.